Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Claudio Galarza–Maldonado"'
Publikováno v:
Journal of Translational Autoimmunity, Vol 6, Iss , Pp 100159- (2023)
The complex pathological mechanisms of autoimmune diseases have now been discovered and described, including interactions between innate and adaptive immunity, the principal cells of which are neutrophils and lymphocytes. Neutrophil-to–lymphocyte r
Externí odkaz:
https://doaj.org/article/a6068b9b5c1e450d9e83c6621b15aa8e
Publikováno v:
Antibodies, Vol 6, Iss 1, p 4 (2017)
Neutrophil extracellular traps (NETs) are a network of extracellular fibers, compounds of chromatin, neutrophil DNA and histones, which are covered with antimicrobial enzymes with granular components. Autophagy and the production of reactive oxygen s
Externí odkaz:
https://doaj.org/article/ab8491dbd4f64d3ea532a1df120bf261
Autor:
Pedro Santos-Moreno, Susan Martínez, Linda Ibata, Laura Villarreal, Fernando Rodríguez-Florido, Manuel Rivero, Adriana Rojas-Villarraga, Claudio Galarza-Maldonado
Publikováno v:
Biologics: Targets and Therapy. 16:107-117
Pedro Santos-Moreno,1 Susan Martinez,1 Linda Ibata,1 Laura Villarreal,1 Fernando RodrÃguez-Florido,1 Manuel Rivero,1 Adriana Rojas-Villarraga,2 Claudio Galarza-Maldonado3 1Scientific Department, Biomab IPS SAS, Bogotá, Colombia; 2Research Insti
Autor:
Eduardo Vásconez-González, María Belén López, Dayana Cuchiparte, Katherine Peláez, Claudio Galarza-Maldonado, Leonardo Cano-Cevallos, Andrés López-Cortés, Esteban Ortiz-Prado
Publikováno v:
Revista Ecuatoriana de Neurologia. 30:76-82
Dentro de las enfermedades autoinmunes destaca el lupus eritematoso sistémico (LES). Esta enfermedad está caracterizada por la afectación de varios órganos y sistemas, entre ellos el sistema nervioso central, en el cual produce diversas complicac
Autor:
Jorge Ponce-Zea, Nathalia Rodríguez-Burneo, Felipe Andrade, Diana C Checa-Jaramilloz, Diana Marcela Castillo, Esteban Ortiz-Prado, Jorge E. Vasconez, Claudio Galarza-Maldonado, Damaris P Intriago Baldeón
Publikováno v:
Generics and Biosimilars Initiative Journal. 9:64-74
The number of approved biological medicines in the global pharmaceutical market has increased in recent decades. However, their high costs have also promoted the development of biosimilar medicines, following the expiry of the patent of the reference
Autor:
M. E. L. Lopez, G. Avila-Pedretti, J. A. Benavides, A. M. Babini, A. P. Ortega, V. F. Azevedo, I. S. Terán, C. Encalada, Pedro Santos-Moreno, Claudio Galarza-Maldonado, S. B. Cohen, B. Garro, Jonathan Kay, Ricardo Machado Xavier, V. J. K. Rodriguez, Sergio Kowalski, Enrique R. Soriano, M. Cifuentes-Alvarado, Antonio Cachafeiro-Vilar, Eduardo Mysler, Carlos Pineda, A. Vargas, P. A. B. Roa, Marlene Guibert-Toledano, A. S. Russell, L. Diaz Soto, Gloria Vásquez, I. A. G. Sariego, D. X. Xibillé Firedman, P. E. Díaz, Carlo V. Caballero-Uribe
Publikováno v:
Clinical Rheumatology. 38:1485-1496
Biologics have improved the treatment of rheumatic diseases, resulting in better outcomes. However, their high cost limits access for many patients in both North America and Latin America. Following patent expiration for biologicals, the availability
Publikováno v:
Journal of Translational Autoimmunity. :100159
Autor:
Carlos Pineda, Igor Age Kos, Osvaldo Castañeda Jimenez, Claudio Galarza-Maldonado, Enrique R. Soriano, Valderílio Feijó Azevedo, Carlos Vinicius Caballero-Uribe
Publikováno v:
JCR: Journal of Clinical Rheumatology. 26:33-36
Autor:
Pedro Santos-Moreno, Enrique R. Soriano, Maria Loreto Massardo, Carlo V. Caballero-Uribe, Mario H. Cardiel, Juan Alberto Benavides, Paula Andrea Beltrán, Carlos Pineda, Claudio Galarza Maldonado
Publikováno v:
Clinical Rheumatology. 36:2855-2858
The implementation of excellence centers in specific diseases has been gaining recognition in the field of health; specifically in rheumatoid arthritis, where the prognosis of the disease is related to an early diagnosis and a timely intervention, it
Autor:
María H. Esteva Spinetti, Fedra Irazoque Palezuelos, Francisco J. Ballesteros, Geraldo da Rocha Castelar-Pinheiro, Janitzia Vázquez-Mellado, Ángel F. Achurra-Castillo, Simone Appenzeller, Sebastião Cezar Radominski, Ignacio García-De La Torre, Mario H. Cardiel, Carlo V. Caballero-Uribe, Rubén Montufar, Carlos Rios, Lilia Andrade-Ortega, Pablo Monge, Enrique R. Soriano, Mónica P. Sacnun, Jorge A. Esquivel-Valerio, Cristiano A. F. Zerbini, Adriana Rojas-Villarraga, Verónica Saurit, Raquel Teijeiro, Washington A. Bianchi, Rocío V. Gamboa-Cárdenas, Bernardo A. Pons-Estel, Manuel F. Ugarte-Gil, Cecilia Pisoni, Leonor A Barile-Fabris, Marlene Guibert-Toledano, Inês Guimarães da Silveira, Graciela S. Alarcón, Loreto Massardo, Claudio Galarza-Maldonado
Publikováno v:
Clinical rheumatology. 38(10)
To identify baseline predictors of remission and low disease activity (LDA) in early rheumatoid arthritis (RA) from the GLADAR (Grupo Latino Americano De estudio de la Artritis Reumatoide) cohort.Patients with 1- and 2-year follow-up visits were incl